Skip to content
★ Sign in to follow
KF

Karen Fisher

CFO
KORU Medical Systems, Inc.Gilman & Ciocia Inc
Total declarations
7
Companies
2
▲ Purchases (3 ops.)
€5,633
▼ Sales (0 ops.)
—

Latest filing published 07 Dec 2020 for KORU Medical Systems, Inc., €2,310.

Filing timeline

BuySale
Karen Fisher

Insider track record

Disclosed buys
3
Disclosed sells
0
Signal history

Closed purchases

Market purchases
3
Positive at T+90
0%
Median T+90
-36.3%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Karen Fisher: trading record in brief

Filings by Karen Fisher span 2 companies, the busiest being KORU Medical Systems, Inc. and Gilman & Ciocia Inc. In total, 7 filings cover trades dated from 20 August 2007 to 7 December 2020.

No open-market sale appears; the market trades are 3 purchases worth €5,633. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant and 3 option exercises. Since January 2020: 2 purchases and no sales on the market.

The median purchase comes to €2,230.

Most recently, on 7 December 2020, the filings show an open-market purchase worth €2,310 in KORU Medical Systems, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Karen Fisher

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations7 total
  • ▲
    Chief Financial OfficerExecutivesKORU Medical Systems, Inc.
    2,800 USD39SEC
    500 shares@ US$5.600.4% of flowCommon StockSEC:0001161697-20-000521:0
    Canonical exit: 7 Mar 2021 (T+90)
  • ▲
    Chief Financial OfficerExecutivesKORU Medical Systems, Inc.
    1,325 USD37SEC
    250 shares@ US$5.300.2% of flowCommon StockSEC:0001161697-20-000516:0
    Canonical exit: 3 Mar 2021 (T+90)
  • ◆
    Chief Financial OfficerExecutivesKORU Medical Systems, Inc.
    322,294 USD24SEC
    27,844 shares@ US$11.57549.7% of flowCommon StockSEC:0001161697-20-000201:0
  • ◇
    Chief Financial OfficerExecutivesKORU Medical Systems, Inc.
    165,300 USD22SEC
    435,000 shares@ US$0.3825.5% of flowCommon StockSEC:0001161697-20-000201:1
  • ◇
    Chief Financial OfficerExecutivesKORU Medical Systems, Inc.
    157,000 USD21SEC
    100,000 shares@ US$1.5724.2% of flowCommon StockSEC:0001161697-20-000201:2
  • ◇
    Chief Financial OfficerExecutivesKORU Medical Systems, Inc.
    24,700 USD19SEC
    65,000 shares@ US$0.383.6% of flowCommon StockSEC:0001161697-19-000193:0
  • ▲
    Chief Accounting OfficerExecutivesGilman & Ciocia Inc
    3,000 USD0SEC
    30,000 shares@ US$0.10Common StockSEC:0001193805-07-002178:0
    Canonical exit: 18 Nov 2007 (T+90)

7 of 7 declarations